Kits for cfDNA purification from high volumes of plasma
The chemagic™ cfDNA kits for high volume cfDNA purification from plasma are designed for the processing of 6 - 10 ml, 15 ml or 18 ml plasma with minimal hands-on time on the chemagic™ 360 instrument . The kits are designed for use with human plasma samples derived from EDTA, citrate or Streck® Cellfree DNA BCT® tubes. In addition, fresh and frozen plasma can be used.
- Designed for use with the chemagic™ 360 instrument for high-throughput cfDNA purification
- Proprietary technology based on the use of M-PVA Magnetic Beads for optimal nucleic acid yield and purity
- Disposable plasticware included
- Convenient packaging to reduce reagent waste
- Reagents can be stored at room temperature
- 1 - 30 ng cfDNA/ml plasma
Please find below a selection of available kits for cfDNA isolation from high volumes of plasma (6 to 18 ml) using chemagic™ instruments, or a manual procedure. For different sample volumes please refer to the kit selection page.
Kits for chemagic™ automation
*Additional accessories required: 3 quantity chemagic 13 mL Double Bottom Rack H24 (art. No. CMG-13005340)
The chemagic™ cfDNA for medium volumes of plasma are based on chemagic™ Technology using M-PVA Magnetic Beads. The cfDNA binds to paramagnetic beads which are magnetically separated from the sample material. During subsequent steps contaminants are removed and the purified cfDNA is transferred into an elution medium. The automated sample processing by the chemagic™ 360 instrument excludes cross contamination and ensures safe handling of infectious sample material.
Plasma Preparation Protocol
Plasma Preparation Protocol
It is recommended to prepare plasma as fresh as possible (max. 5 days after blood draw). Longer storage of blood prior to plasma preparation may lead to poor separation results and higher background from genomic DNA.
A double centrifugation protocol during plasma preparation is recommended to minimize the potential for contamination of plasma with cells and genomic DNA. Transfer of any other blood components (buffy coat or red blood cells) should be avoided while separating the plasma fraction.
Please refer to the tube manufacturers specifications (max. centrifugation speed) for more information.
From 10 mL of whole blood approximately 4 - 5 mL plasma can be expected.
- Centrifuge whole blood collection tube at 2000 x g for 20 minutes.
- Aspirate plasma carefully and at least 2 - 3 mm above the buffy coat layer, without disturbing the layer and transfer it into a new appropriate tube.
- Centrifuge the plasma sample at 3300 x g for 30 minutes.
- Carefully transfer the supernatant to a fresh tube without disturbing the pellet, at least 2 - 3 mm above the pellet.
- For direct use storage of plasma sample at 2 - 8 °C is possible, for long-term storage -80 °C is recommended.
Lefèvre AC, Pallisgaard N, Kronborg C, Wind KL, Krag SRP, Spindler KG. The Clinical Value of Measuring Circulating HPV DNA during Chemo-Radiotherapy in Squamous Cell Carcinoma of the Anus. Cancers (Basel). 2021 May 18;13(10):2451.
Yu J, Cho E, Choi J, Lim JE, Lee J, Kang M, Sung HH, Jeong BC, Seo SI, Jeon SS, Lee HM, Jeon HG. Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance. Investig Clin Urol. 2021 Mar;62(2):224-232.
Moon SM, Kim JH, Kim SK, Kim S, Kwon HJ, Bae JS, Lee S, Lee HS, Choi MY, Jeon BH, Jeong BH, Lee K, Kim HK, Kim J, Um SW. Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer. Anticancer Res. 2020 Jun;40(6):3435-3444.
For research use only. Not for use in diagnostic procedures.